论文部分内容阅读
雷公藤多甙于 1 981年始国内临床用于治疗肾病综合征 ,认为通过改变肾小球基底膜电荷屏障而减少尿蛋白〔1 ,2〕,但其治疗效果究竟如何 ,临床报道不多 ,我们对 3 4例肾综Ⅰ型的病人治疗情况予以对比观察 ,现报道如下。临床资料3 4例病人为住院和门诊治疗病人 ,临床上符合肾综Ⅰ?
Tripterygium glycosides in 1981 began clinical treatment of nephrotic syndrome in the country, that by changing the glomerular basement membrane charge barrier and reduce urinary protein 〔1, 2〕, but the treatment effect of how, few clinical reports, we 34 cases of renal comprehensive type Ⅰ treatment of patients to be compared, are reported below. Clinical data 34 patients for inpatient and outpatient treatment of patients, clinically consistent with renal comprehensive Ⅰ?